IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades Robinhood, sees 43% upside
• Rezolve Ai posts $130.8M in H1 revenue, net loss widens to $139.5M
• Draganfly wins FAA exemption for heavy-lift drone over 55 pounds